We summarize the week's scientific breakthroughs every Thursday.
The biggest fibromyalgia genetics study yet zeroed in on 26 genetic risk factors for the pain disorder, including one in the Huntington's disease gene.
Many people struggle to sleep enough at night. Surprisingly, science cannot say if adding in a nap to sleep in two blocks is healthy.
Three species preferred different people based on their skin odor and bacteria. The findings could help make new microbe-based repellants.
A personalized mRNA vaccine paired with Keytruda may help keep skin cancer from returning after surgery, a large clinical trial suggests.
Children exposed to World War II sugar rationing had lower dementia and Alzheimer’s risk decades later, data suggest.
A week-long brain mapping session can lead to lasting relief, a case series of three pain patients shows.
A sound wave–based therapy commonly used to dislodge kidney stones is gaining traction as a treatment for erectile dysfunction.
The Epstein-Barr virus has taken a huge toll on global health. Understanding how it works could offer ways to combat multiple sclerosis, cancer and more.
In fall of 2025, the Trump administration touted the drug leucovorin for autism therapy without new evidence. Dispensing of the drug to kids rose.
